Dotinurad (Urece) is a drug for the treatment of
gout
Gout ( ) is a form of inflammatory arthritis characterized by recurrent attacks of pain in a red, tender, hot, and Joint effusion, swollen joint, caused by the deposition of needle-like crystals of uric acid known as monosodium urate crysta ...
and
hyperuricemia
Hyperuricaemia or hyperuricemia is an abnormally high level of uric acid in the blood. In the pH conditions of body fluid, uric acid exists largely as urate, the ion form. Serum uric acid concentrations greater than 6 mg/dL for females, 7 ...
.
It was
developed by
Fuji Yakuhin and approved for use in Japan in 2020.
The drug is continuing clinical trials by Fortress Biotech and regulatory evaluation for approval in North America and Europe.[
Dotinurad acts as a selective urate reabsorption inhibitor that has ]uric acid
Uric acid is a heterocyclic compound of carbon, nitrogen, oxygen, and hydrogen with the Chemical formula, formula C5H4N4O3. It forms ions and salts known as urates and acid urates, such as ammonium acid urate. Uric acid is a product of the meta ...
lowering activity by inhibiting URAT1
Solute carrier family 22 (organic anion/cation transporter), member 12, also known as SLC22A12 and URAT1, is a protein which in humans is encoded by the ''SLC22A12'' gene.
Function
The protein encoded by this gene is a uric acid, urate transpor ...
/SLC22A12
Solute carrier family 22 (organic anion/cation transporter), member 12, also known as SLC22A12 and URAT1, is a protein which in humans is encoded by the ''SLC22A12'' gene.
Function
The protein encoded by this gene is a urate transporter and ura ...
receptor. It and epaminurad
Epaminurad is an investigational new drug being developed by JW Pharmaceutical for the treatment of gout and hyperuricemia. It is a urate-lowering agent that selectively inhibits the human SLC22A12, uric acid transporter 1 (hURAT1), promoting ur ...
are structural analogs of Benzbromarone
Benzbromarone is a uricosuric agent and non-competitive inhibitor of xanthine oxidase used in the treatment of gout, especially when allopurinol, a first-line treatment, fails or produces intolerable adverse effects. It is structurally related to ...
.
References
{{reflist
Antigout agents
Phenols
Chlorobenzene derivatives
Benzothiazoles